Five subtypes of common liver disease discovered—including rapidly progressing genetic forms

A recent study by Mayo Clinic researchers has revealed that a liver condition affecting nearly 30 % of adults worldwide is not a single disease but actually comprises five biologically distinct subtypes. The investigation, which analyzed large patient cohorts and molecular data, identified these subtypes as having markedly different clinical trajectories and risk profiles.

Each subtype was found to carry its own set of complications. Some patients face a higher likelihood of progressing to heart disease, while others are more prone to liver failure or developing liver cancer. Moreover, the need for liver transplantation varies across the groups, underscoring the importance of precise diagnosis. The study’s authors emphasize that treating the condition as a homogeneous entity may overlook these critical differences, potentially leading to suboptimal management.

The findings suggest that a more nuanced classification could inform personalized treatment strategies and improve prognostication. By tailoring interventions to the specific subtype, clinicians may better mitigate the risk of severe outcomes and enhance patient care.